| ACV | acyclovir |
| ADCC | antibody-dependent cell-mediated cytotoxicity |
| AMV | Amenamevir |
| ATP | adenosine triphosphate |
| BCDV | brincidofovir |
| BVDU | Brivudin |
| CDV | cidofovir |
| CMV | cytomegalovirus |
| CNS | central nervous system |
| dNTPs | deoxyribonucleotides triphosphate |
| dsDNA | double-stranded DNA |
| EBV | Epstein–Barr virus |
| EC50 | half-maximal effective concentration |
| FCV | famciclovir |
| FCV | filociclovir |
| FDA | Food and Drug Administration |
| FOS | foscarnet |
| gB | glycoprotein B |
| GCV | ganciclovir |
| gD | glycoprotein D |
| HBV | hepatitis B virus |
| HHV6 | human herpesvirus |
| HP | helicase-primase complex |
| HPIs | helicase-primase inhibitors |
| HPV | human papillomavirus |
| HSC | hematopoietic stem cell |
| HSV-1 | herpes simplex virus type 1 |
| HSV-2 | herpes simplex virus type 2 |
| IDU | iododeoxyuridine |
| KSHV | Kaposi’s sarcoma-associated herpesvirus |
| LMV | letermovir |
| MBV | maribavir |
| MBZM-N-IBT1 | [(2-methyl benzimidazole-1-yl) methyl]-2-oxo-indolin-3-ylidene] amino] thiourea |
| MDV | Marek’s disease virus |
| PCV | penciclovir |
| PRV | pseudorabies virus |
| PTV | pritelivir |
| SOT | solid organ transplant |
| ssDNA | single-stranded DNA |
| TFD | trifluridine |
| TK | thymidine kinase |
| VACV | valacyclovir |
| VDR | vidarabine |
| VGCV | valganciclovir |
| VZIG | varicella-zoster immune globulin |
| VZV | varicella-zoster virus |